The 7th International Keto Live® Conference brings together healthcare professionals, medical researchers, nutrition specialists, scientists, and other experts interested in metabolic health and ketogenic metabolic therapies. Taking place from 19 to 22 June 2027 at the Swiss Re Centre for Global Dialogue in Rüschlikon, near Zurich, the conference provides an international platform for scientific exchange, interdisciplinary collaboration, and discussion of emerging developments in metabolic medicine.

Under the theme of ketogenic metabolic therapies in the prevention and treatment of non-communicable diseases, the conference explores the scientific evidence, clinical applications, and evolving research surrounding ketogenic approaches to health. Topics may include metabolic health, nutritional ketosis, neurological conditions, metabolic disorders, therapeutic nutrition, and the relationship between metabolism and chronic disease.

The programme is designed to encourage knowledge exchange between clinicians, researchers, dietitians, and other professionals working across medicine, nutrition, and health sciences. Scientific presentations, discussions, and research contributions offer opportunities to examine current evidence, consider clinical experiences, and identify areas for further investigation. The conference also supports continuing medical education, with CME/CPD recognition listed by several professional medical and nutrition organizations.

By bringing together expertise from different disciplines and countries, the International Keto Live® Conference promotes dialogue on the role of metabolic therapies in modern healthcare. It provides a forum for examining research findings, discussing practical challenges, and exploring how scientific advances can inform responsible, evidence-based clinical practice.

Join the 7th International Keto Live® Conference in Switzerland to connect with the international metabolic health community, exchange scientific insights, and engage with current research into ketogenic metabolic therapies and their potential role in addressing non-communicable diseases.